Outcome Measures in Rheumatology (OMERACT) conferences have developed a process by which outcome measures to be included in clinical trials are identified by consensus. During OMERACT 7, held in Asilomar, CA, USA, in May 2004, a workshop on outcome measures in psoriatic arthritis was held. Information derived through a previous Delphi exercise and nominal group process was shared with the participants, as were the results from a study using completed clinical trials with biological therapies. On the basis of the evidence presented and discussions in breakout groups at the OMERACT conference, a set of domains to be included in clinical trials in psoriatic arthritis was developed and a research agenda for further studies in psoriatic arthritis proposed. [References: 11]
ContributorsGladman, D. D. Strand, V. Mease, P. J. Antoni, C. Nash, P. Kavanaugh, A.
Disease Category: Rheumatology
Disease Name: Psoriatic arthritis
Age Range: Unknown
Sex: Either
Nature of Intervention: Not specified
- Clinical experts
- Recommendations for outcome measures (measurement/how)
- COS for clinical trials or clinical research
- COS for practice
- Semi structured discussion
Semi structured discussion: workshop and meeting